C
VXZ icon

Cerebellum’s iPath Series B S&P 500 VIX Mid-Term Futures ETN VXZ Stock Holding History

Cerebellum’s Portfolio VXZ Stock Details VXZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-143
Closed -$10K – 524
2019
Q1 		$10K Buy
+143
New +$11K 0.01% 399

Other funds holding VXZ

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
BWA
BDO Wealth Advisors Jacksonville, Florida $872M AUM 15.17% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cerebellum's VXZ Position: Q2 2019 in Review

Cerebellum sold out of iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) in Q2 2019, closing a stake of 143 shares — an estimated $10K sold.

Cerebellum first reported a position in VXZ in Q1 2019 and held it in 1 quarter. The position peaked at $10K in Q1 2019. 5 funds tracked by Wall St. Rank hold VXZ as of Q2 2019.

  • Cerebellum reported no remaining iPath Series B S&P 500 VIX Mid-Term Futures ETN position as of Q2 2019 after selling out during the quarter.
  • Cerebellum sold 143 iPath Series B S&P 500 VIX Mid-Term Futures ETN shares in Q2 2019, an estimated $10K.
  • Cerebellum first reported a position in iPath Series B S&P 500 VIX Mid-Term Futures ETN in Q1 2019 and held it in 1 quarter.
  • Cerebellum's iPath Series B S&P 500 VIX Mid-Term Futures ETN position peaked at $10K in Q1 2019.
  • 5 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Mid-Term Futures ETN as of Q2 2019.

Based on Cerebellum's 13F filing for Q2 2019, filed 19 Jul 2019.